Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma

Keishi Yamashita, Yoichi Tanaka, Koshi Mimori, Hiroshi Inoue, Masaki Mori

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Matrix metalloproteinase (MMP) is critical for carcinoma progression. In our study, we evaluated the prognostic significance of the major MMP family such as MMP-3, MMP-9, MMP-11 and MT1-MMP at the mRNA in 44 esophageal squamous cell carcinoma (ESCC) that were previously characterized for MMP-7, MMP-1 and MMP-2, and their relation to urokinase system (uPA and uPAR). MT1-MMP, MMP-11 and MMP-2 expressions are closely associated with each other, while MMP-9 and uPAR expressions are inversely associated with the former group. There is no MMP related to clinico-pathological factors; however, patients with high MT1-MMP could show worse prognosis, as compared to those with low MT1-MMP expression (p=0.01), as well as MMP-11 did (p=0.02). Both MMP showed clear expression of carcinoma cells by immunohistochemistry. In patients with high MT1-MMP, recurrence was more prominent (23/26: 88.5%) than those with low MT1-MMP (7/18: 38.9%) (p=0.0016). In the 20 cases who died within 3 years, all 15 cases with high MT1-MMP showed initial recurrence of distant metastasis, and the other 5 cases with low MT1-MMP showed locoregional recurrence (p=0.000064). These results could indicate that there is a relevant mechanism of associated expression of clinically significant MMP and that among them, MT1-MMP plays the most critical role in ESCC progression.

Original languageEnglish
Pages (from-to)201-207
Number of pages7
JournalInternational Journal of Cancer
Volume110
Issue number2
DOIs
Publication statusPublished - Jun 10 2004

Fingerprint

Matrix Metalloproteinase 14
Matrix Metalloproteinases
Matrix Metalloproteinase 11
Matrix Metalloproteinase 7
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Recurrence
Carcinoma
Esophageal Squamous Cell Carcinoma
Matrix Metalloproteinase 3
Matrix Metalloproteinase 1
Urokinase-Type Plasminogen Activator
Immunohistochemistry
Neoplasm Metastasis
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma. / Yamashita, Keishi; Tanaka, Yoichi; Mimori, Koshi; Inoue, Hiroshi; Mori, Masaki.

In: International Journal of Cancer, Vol. 110, No. 2, 10.06.2004, p. 201-207.

Research output: Contribution to journalArticle

@article{2096e3d8691540b2a8009c42c08745ea,
title = "Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma",
abstract = "Matrix metalloproteinase (MMP) is critical for carcinoma progression. In our study, we evaluated the prognostic significance of the major MMP family such as MMP-3, MMP-9, MMP-11 and MT1-MMP at the mRNA in 44 esophageal squamous cell carcinoma (ESCC) that were previously characterized for MMP-7, MMP-1 and MMP-2, and their relation to urokinase system (uPA and uPAR). MT1-MMP, MMP-11 and MMP-2 expressions are closely associated with each other, while MMP-9 and uPAR expressions are inversely associated with the former group. There is no MMP related to clinico-pathological factors; however, patients with high MT1-MMP could show worse prognosis, as compared to those with low MT1-MMP expression (p=0.01), as well as MMP-11 did (p=0.02). Both MMP showed clear expression of carcinoma cells by immunohistochemistry. In patients with high MT1-MMP, recurrence was more prominent (23/26: 88.5{\%}) than those with low MT1-MMP (7/18: 38.9{\%}) (p=0.0016). In the 20 cases who died within 3 years, all 15 cases with high MT1-MMP showed initial recurrence of distant metastasis, and the other 5 cases with low MT1-MMP showed locoregional recurrence (p=0.000064). These results could indicate that there is a relevant mechanism of associated expression of clinically significant MMP and that among them, MT1-MMP plays the most critical role in ESCC progression.",
author = "Keishi Yamashita and Yoichi Tanaka and Koshi Mimori and Hiroshi Inoue and Masaki Mori",
year = "2004",
month = "6",
day = "10",
doi = "10.1002/ijc.20067",
language = "English",
volume = "110",
pages = "201--207",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma

AU - Yamashita, Keishi

AU - Tanaka, Yoichi

AU - Mimori, Koshi

AU - Inoue, Hiroshi

AU - Mori, Masaki

PY - 2004/6/10

Y1 - 2004/6/10

N2 - Matrix metalloproteinase (MMP) is critical for carcinoma progression. In our study, we evaluated the prognostic significance of the major MMP family such as MMP-3, MMP-9, MMP-11 and MT1-MMP at the mRNA in 44 esophageal squamous cell carcinoma (ESCC) that were previously characterized for MMP-7, MMP-1 and MMP-2, and their relation to urokinase system (uPA and uPAR). MT1-MMP, MMP-11 and MMP-2 expressions are closely associated with each other, while MMP-9 and uPAR expressions are inversely associated with the former group. There is no MMP related to clinico-pathological factors; however, patients with high MT1-MMP could show worse prognosis, as compared to those with low MT1-MMP expression (p=0.01), as well as MMP-11 did (p=0.02). Both MMP showed clear expression of carcinoma cells by immunohistochemistry. In patients with high MT1-MMP, recurrence was more prominent (23/26: 88.5%) than those with low MT1-MMP (7/18: 38.9%) (p=0.0016). In the 20 cases who died within 3 years, all 15 cases with high MT1-MMP showed initial recurrence of distant metastasis, and the other 5 cases with low MT1-MMP showed locoregional recurrence (p=0.000064). These results could indicate that there is a relevant mechanism of associated expression of clinically significant MMP and that among them, MT1-MMP plays the most critical role in ESCC progression.

AB - Matrix metalloproteinase (MMP) is critical for carcinoma progression. In our study, we evaluated the prognostic significance of the major MMP family such as MMP-3, MMP-9, MMP-11 and MT1-MMP at the mRNA in 44 esophageal squamous cell carcinoma (ESCC) that were previously characterized for MMP-7, MMP-1 and MMP-2, and their relation to urokinase system (uPA and uPAR). MT1-MMP, MMP-11 and MMP-2 expressions are closely associated with each other, while MMP-9 and uPAR expressions are inversely associated with the former group. There is no MMP related to clinico-pathological factors; however, patients with high MT1-MMP could show worse prognosis, as compared to those with low MT1-MMP expression (p=0.01), as well as MMP-11 did (p=0.02). Both MMP showed clear expression of carcinoma cells by immunohistochemistry. In patients with high MT1-MMP, recurrence was more prominent (23/26: 88.5%) than those with low MT1-MMP (7/18: 38.9%) (p=0.0016). In the 20 cases who died within 3 years, all 15 cases with high MT1-MMP showed initial recurrence of distant metastasis, and the other 5 cases with low MT1-MMP showed locoregional recurrence (p=0.000064). These results could indicate that there is a relevant mechanism of associated expression of clinically significant MMP and that among them, MT1-MMP plays the most critical role in ESCC progression.

UR - http://www.scopus.com/inward/record.url?scp=2342580668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342580668&partnerID=8YFLogxK

U2 - 10.1002/ijc.20067

DO - 10.1002/ijc.20067

M3 - Article

C2 - 15069682

AN - SCOPUS:2342580668

VL - 110

SP - 201

EP - 207

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -